Literature DB >> 11360192

Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway.

S C Santos1, V Lacronique, I Bouchaert, R Monni, O Bernard, S Gisselbrecht, F Gouilleux.   

Abstract

Signal Transducer and Activator of Transcription (STATs) are important mediators of cytokine and growth factor-induced signal transduction. STAT5A and STAT5B have been shown to play a role in survival and proliferation of hematopoietic cells both in vitro and in vivo and to contribute to the growth and viability of cells transformed by the TEL-JAK2 oncoprotein. In this study, we investigated the molecular mechanisms by which constitutively active STAT5 proteins induce cell proliferation and survival of Ba/F3 cell lines expressing either dominant positive STAT5A or STAT5B variants or TEL-JAK2 or TEL-ABL fusion proteins. Our results showed that active STAT5 constitutively interacted with p85, the regulatory subunit of the PI 3-kinase. A constitutive activity of the PI 3-kinase/Akt pathway was observed in these cells and required for their cell cycle progression. In contrast, while activity of the PI 3-kinase/Akt pathway was required for survival of Ba/F3 cells expressing the constitutively active forms of STAT5A or STAT5B, it was dispensable for cells transformed by TEL-JAK2 or TEL-ABL fusion proteins, suggesting that additional survival pathways take place in these transformed cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11360192     DOI: 10.1038/sj.onc.1204308

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

1.  STAT5 acts as a repressor to regulate early embryonic erythropoiesis.

Authors:  Matthew Schmerer; Ingrid Torregroza; Aude Pascal; Muriel Umbhauer; Todd Evans
Journal:  Blood       Date:  2006-07-11       Impact factor: 22.113

2.  Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1.

Authors:  Bradley A Creamer; Kazuhito Sakamoto; Jeffrey W Schmidt; Aleata A Triplett; Richard Moriggl; Kay-Uwe Wagner
Journal:  Mol Cell Biol       Date:  2010-04-12       Impact factor: 4.272

3.  Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter.

Authors:  Rémy Nyga; Christian Pecquet; Noria Harir; Haihua Gu; Isabelle Dhennin-Duthille; Aline Régnier; Valérie Gouilleux-Gruart; Kaïss Lassoued; Fabrice Gouilleux
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

Review 4.  Crosstalk between STAT5 activation and PI3K/AKT functions in normal and transformed mammary epithelial cells.

Authors:  Patrick D Rädler; Barbara L Wehde; Kay-Uwe Wagner
Journal:  Mol Cell Endocrinol       Date:  2017-05-08       Impact factor: 4.102

5.  Murine leukemia retrovirus integration induces the formation of transcription factor complexes on palindromic sequences in the signal transducer and activator of transcription factor 5a gene during the development of pre-B lymphomagenesis.

Authors:  Tatsuaki Tsuruyama; Takuya Hiratsuka; Guang Jin; Yukiko Imai; Haruya Takeuchi; Yasuhiro Maruyama; Kazuya Kanaya; Munetaka Ozeki; Tetsuya Takakuwa; Hironori Haga; Keiji Tamaki; Takuro Nakamura
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

Review 6.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

7.  Mechanism for IL-15-Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response Proteins.

Authors:  Rashmi Gupta; Wentian Li; Xiao J Yan; Jacqueline Barrientos; Jonathan E Kolitz; Steven L Allen; Kanti Rai; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  J Immunol       Date:  2019-04-15       Impact factor: 5.422

8.  The tumor suppressor hTid1 inhibits STAT5b activity via functional interaction.

Authors:  Isabelle Dhennin-Duthille; Rémy Nyga; Saliha Yahiaoui; Valérie Gouilleux-Gruart; Aline Régnier; Kaïss Lassoued; Fabrice Gouilleux
Journal:  J Biol Chem       Date:  2010-11-24       Impact factor: 5.157

9.  Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis.

Authors:  Inês Sofia Vala; Leila R Martins; Natsuko Imaizumi; Raquel J Nunes; José Rino; François Kuonen; Lara M Carvalho; Curzio Rüegg; Isabel Monteiro Grillo; João Taborda Barata; Marc Mareel; Susana Constantino Rosa Santos
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

Review 10.  Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations.

Authors:  Jaclyn LoPiccolo; Gideon M Blumenthal; Wendy B Bernstein; Phillip A Dennis
Journal:  Drug Resist Updat       Date:  2007-12-31       Impact factor: 18.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.